AlphaStocks
7.5
Strong Buy

Harmony Biosciences Holdings, Inc. (HRMY)

As of Sep 20, 2026, Harmony Biosciences Holdings, Inc. (HRMY) scores 7.5/10 on AlphaStocks' five-model composite, #5 of 168 Health Care stocks.

Health Care / Biotechnology

S&P SmallCap 600

$42.06

Above average across most dimensions. A solid candidate.

Strong Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#5out of 168 in Health Care

Is Harmony Biosciences Holdings, Inc. a Good Investment in 2026?

Harmony Biosciences Holdings, Inc. (HRMY) scores 7.5 out of 10 on AlphaStocks' composite model, earning a Strong Buy rating. The Lynch model rates Harmony Biosciences Holdings, Inc. as Strong (PEG 0.2 · Fast Grower). The Graham model is the least favorable, rating it Neutral. Harmony Biosciences Holdings, Inc. ranks #5 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E15.5ROE18.6Market Cap2B

Valuation

Trades at 16x earnings — near sector median of 30x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

22% above fair value

Lynch

Strong

PEG 0.2 · Fast Grower

Greenblatt

Strong

Earnings yield 13.3% · ROC 49%

Frequently Asked Questions

Is Harmony Biosciences Holdings, Inc. (HRMY) a good investment?
As of Sep 20, 2026, Harmony Biosciences Holdings, Inc. (HRMY) scores 7.5/10 on AlphaStocks' five-model composite, #5 of 168 Health Care stocks. That score is above average across most investment dimensions. Trades at 16x earnings — near sector median of 30x.
What is Harmony Biosciences Holdings, Inc.'s Piotroski F-Score?
Harmony Biosciences Holdings, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HRMY overvalued or undervalued?
A precise fair value estimate is not available for HRMY. Trades at 16x earnings — near sector median of 30x.
How does HRMY compare to other Health Care stocks?
Harmony Biosciences Holdings, Inc. ranks #5 out of 168 stocks in the Health Care sector, placing it in the top 3% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about HRMY?
AlphaStocks evaluates HRMY using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Strong; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 7.5/10.

Similar Stocks

ABBVINCYHALO

Compare HRMY with

ABBV vs HRMYHRMY vs INCYHALO vs HRMYHRMY vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer